GlassScriptPhysician profile
Connie J Decker
NPI 1902860265
$3,017.84
in general payments reported to CMS, 2019-2025
21 companies · $522 in 2025
The $522 reported for 2025 was more than what 84% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $144 · 2022: $695 · 2023: $1,015 · 2024: $642 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.72 |
| Education | $189.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.60 | 2021-2024 | |
| Organon LLC | $365.35 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $358.82 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $353.95 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $337.24 | 2021-2025 | |
| Hologic Sales and Service, LLC | $165.98 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $126.03 | 2023-2024 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $122.71 | 2023-2024 | |
| Millicent US INC | $99.51 | 2025 | Intrarosa, Femlyv |
| Exact Sciences Corporation | $96.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $77.55 | 2021-2024 | |
| Shield Therapeutics INC | $73.27 | 2023-2024 | Accrufer |
| Axonics, INC. | $65.98 | 2024 | Axonics |
| Amgen INC. | $62.91 | 2022-2024 | Prolia, Evenity |
| Myriad Women'S Health, INC. | $42.99 | 2023 | Myrisk |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $38.96 | 2022 | |
| Sage Therapeutics, LLC | $36.91 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $35.61 | 2021-2022 | |
| Scynexis, INC. | $21.62 | 2022 | |
| Boston Scientific Corporation | $19.97 | 2025 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.70 | 2024 | Xifaxan, Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.